PharmaShots | Incisive News in 3 Shots

Subscribe Now

EMPOWER-Lung 3 Trial

Regeneron and Sanofi Stop P-III EMPOWER-Lung 3 Trial Early Due to Improvement in OS for 1L Treatment of NSCLC

Regeneron and Sanofi Stop P-III EMPOWER-Lung 3 Trial Early Due to Improvement in OS for 1L Treatment of NSCLC

August 5, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us